Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
[68Ga]Ga-FAPI-46 PET/CT in Adrenocortical Neoplasm, Oncocytic Type.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 13, 2025
Beyond the Prostate: Incidental Detection of Male Breast Carcinoma on [18F]DCFPyl.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 12, 2025
When PSMA lights up the thyroid: an incidental discovery of a second primary on [68Ga]Ga-PSMA-11.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 16, 2025
FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 19, 2024
Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 21, 2023
Neural-hematopoietic-inflammatory axis in nonsmokers, electronic cigarette users, and tobacco smokers.
Journal: Physiological reports
Published: March 24, 2022
Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: February 15, 2022
Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312).
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 05, 2021
A 3-Year-Old Girl With Recent Onset of Seizures and Asymmetric Hypermetabolic Activity on 18F-FDG PET/CT.
Journal: Clinical nuclear medicine
Published: April 22, 2021
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 20, 2021
Quality Improvement Initiatives to Assess and Improve PET/CT Injection Infiltration Rates at Multiple Centers.
Journal: Journal of nuclear medicine technology
Published: March 04, 2019
Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by 68Ga-PSMA-11 PET/CT.
Journal: Clinical genitourinary cancer
Published: August 14, 2018
Last Updated: 09/26/2026